Going to try to keep this brief as possible and post some links to studies, along with plenty of speculation, regarding RTIs. As axolotl pointed out, the pertinent studies focus on cells where endogenous reverse transcriptase is highly expressed (cancerous and embryonic cells), and endogenous RTs shouldn’t be expressing at appreciable levels in healthy adult cells, meaning this RT inhibition is likely to be irrelevant to us. Also, 1 or 2 guys experiencing improvement during a certain treatment doesn’t mean much according to the history of the many other previous recovery/remission stories.
Still, the recent discussion around PFS and PrEP, Truvada, and Nevirapine is interesting for several reasons:
-
The study axolotl posted where restoration of normal growth and the re-expression of a few androgen-responsive genes was achieved upon DHT stimulation after hormone-resistant cells were treated with high concentrations of Nevirapine. An AR blocker prevented this effect of DHT on nevirapine-treated cells. This showed that nevirapine did restore the androgen signalling pathway’s sensitivity to stimulation by androgens.
-
I went looking for other stories of an effect of Truvada in “normal” people and potential unrecognized cases of “PFS” and found dozens of men and a few women reporting an unanticipated increase in sexual function, sometimes to the extreme, after starting PrEP medications. I could not find one person claiming a benefit from anti-retrovirals other than reverse-transcriptase inhibitors and cocktails containing an RTI. This was mainly limited to Atripla (Efavirenz, Emitricitabine, Tenofovir combo) and other drugs containing Efavirenz. There are a few others found via google search beside irishguy754 who had unexpected benefits from Truvada (Emitricitibine, Tenofovir combo) alone.
-
With the few exceptions taking Truvada, all of the people claiming increased libido and/or erections were taking PrEP or HIV treatment regimens containing Efavirenz (Atripla, Tribuss, and Sustiva), Etravirine (Intelence), or Rilpivirine (Edurant, Complera, Odefsey), which are non-nucleoside reverse transcitptase inhibitors (NNRTIs), like Nevirapine. A couple of the guys who switched from Efavirenz to Rilpivirine noticed that both had the effect of increased sexual function. One of them mentioned a greater effect of Rilpivirine compared to Efavirenz.
Woke Up With Major Hot Flash/Flush, Atripla? - Living with HIV/AIDS
Question for the men on Atripla… - Living with HIV/AIDS
Wow, Tripping on Atripla! - Living with HIV/AIDS
Rilpivirine? - Living with HIV/AIDS
.
(There are some anecdotes on sites other than POZ.com, but this appears to be the hub of discussion surrounding these types of meds)
.
- Efavirenz has been shown to be a very potent inhibitor of the human reverse transcriptase encoded by LINE-1 and was trialed as a chomotherapeutic in HRPC. It’s effect was seen as non-significant, but prevention of cancer progression appeared to correlate with concentrations of the drug and extreme variation in blood plasma concentration of the drug was observed among patients:
Despite the fact that primary objective of the trial was not met, it was striking to note a high variability in plasma concentrations of the drug that was actually comparable with previously reported concentrations in HIV patients ranging from 125 to 15,230 ng/ml
.
- LINE-1 knock-down using silencing RNAs (siRNA) had a similar effect on proliferation and differentiation of melanoma cells as the NNRTIs had on proliferation and differentiation of PC3 (an androgen insensitive lineage of prostate cancer cells). This doesn’t mean LINE-1 has any direct link with androgen signalling, but shows that its inhibition may normalize cells, leading to normal androgen signalling in the process.
https://www.nature.com/articles/1208562
.
- Abnormal activation of endogenous retroviruses has been implicated in the pathophysiology of certain neurological diseases and cancer.
https://www.cell.com/trends/molecular-medicine/abstract/S1471-4914(18)30031-5
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5250606/
.
Their expression can include reverse transcriptases, along with other proteins, and RTIs have been trialed as a treatment for some of these diseases.
https://jvi.asm.org/content/91/23/e01309-17
.
I don’t see how this could be involved in this condition, but there is always the slightest possibility.
.
-
Rilpivirine is considered more potent, longer-acting, and less harmful than other NNRTIs and a standard dose is 25mg/day. Doses of up to 150mg/day were “well-tolerated” in the clinical trials:
https://academic.oup.com/jac/article/68/2/250/675261
.
My consideration is that the effect of Nevirapine on androgen signalling may be able to be achieved by higher doses of Efavirenz or Rilpivirine, while avoiding the severe toxicity of the required doses of Nevirapine.
.
The Negatives:
-
These types of drugs (NtRTIs and NNRTIs) have been shown to inhibit human telomerase, with tenofovir having a particularly significant impact.
-
Tenofovir can cause kidney problems
-
Efavirenz can cause CNS effects, with many of the patients on the discussion boards mentioning extremely vivid dreams and a mental haze after waking.
-
Rilvirapine was associated with increasing risk of long-QT syndrome (rapid heartbeats) with increasing dosage.
-
There were 7-8 anecdotes of an RTI, or regimen containing an RTI, suspected of causing ED or lowered libido. Most were regimens containing protease inhibitors, but 2-3 anecdotes were truvada or atripla alone.
-
This is failrly speculative without studies directly addressing the effect that RTIs other than Nevirapine have on androgen signaling.
-
The benefits some of these people are noticing on RTIs may not have anything to do with androgen sensitivity.
I have an acquaintance taking Truvada as a prophylactic and he is having no noticeable side effects. Of course, results on a medication may vary, as we have all learned.